COLA Wins Five-Year Nod to Accredit Organ-Match Labs
Published Date: 6/10/2026
Notice
Summary
Great news! COLA is now officially approved to check labs that do histocompatibility testing, which helps match organ and tissue donors with recipients. This approval lasts five years, from July 10, 2026, to June 10, 2031, and means labs have another trusted option for accreditation. If you run or work in these labs, get ready for a smooth new way to stay certified without extra costs.
Analyzed Economic Effects
5 provisions identified: 3 benefits, 2 costs, 0 mixed.
COLA Granted Deeming Authority
CMS has approved the Commission on Laboratory Accreditation (COLA) to accredit laboratories for the specialty of Histocompatibility and granted COLA deeming authority for 5 years, from July 10, 2026 to June 10, 2031. Laboratories accredited by COLA during that period may be treated as meeting CLIA requirements for that specialty.
Fewer Routine State Inspections
If your histocompatibility laboratory is accredited by COLA during July 10, 2026 through June 10, 2031, CMS says you may generally not be subject to routine inspections by a State survey agency because COLA accreditation can serve as evidence you meet CLIA requirements. This applies specifically to the specialty of Histocompatibility while COLA’s deeming authority is in effect.
Federal Validation and Complaint Surveys
Even if accredited by COLA, histocompatibility laboratories remain subject to Federal validation inspections on a representative-sample basis and to complaint-driven inspections performed by CMS, its agents, or State survey agencies. These federal checks are an ongoing process while COLA’s deeming authority is in effect.
Probation or Withdrawal Risk for COLA
CMS may impose a probationary period of up to 1 year or withdraw COLA’s approval before June 10, 2031 if COLA fails to maintain requirements equal to or more stringent than CLIA or if widespread problems exist in monitoring, inspection, or enforcement. CMS will publish a Federal Register notice explaining the basis if approval is removed.
Enforcement Reporting and Appeals Process
COLA must report actions that deny, suspend, or revoke a laboratory’s accreditation to CMS within 30 days and provides an appeal process for laboratories that have had accreditation denied, suspended, or revoked. Those procedures apply to COLA-accredited histocompatibility laboratories while COLA’s deeming authority is in effect.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-10890 — Medicare Program; Alternative Payment Model Updates and the Increasing Organ Transplant Access (IOTA) Model
Starting July 1, 2026, Medicare is updating the Increasing Organ Transplant Access (IOTA) Model to help kidney transplant hospitals do even better at getting more people transplanted and improving care quality. These changes affect hospitals involved in kidney transplants and aim to make the process smoother and more effective, with new payment rules that reward success. This update is part of a 6-year plan running through 2031 to save more lives and boost patient experience.
2026-10292 — Medicaid Program; Medicaid Managed Care State Directed Payments and Medicaid Fee-for-Service Targeted Medicaid Practitioner Payments
This proposed rule changes how states can pay Medicaid managed care plans and certain doctors to make sure payments are fair, efficient, and encourage enough providers to offer quality care. It affects states, Medicaid managed care organizations, and targeted Medicaid practitioners, aiming to keep payments balanced and services available. Comments on these changes are open until July 21, 2026, so stakeholders have time to weigh in before it’s finalized.
2026-10050 — Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program
Starting in 2027, health insurance plans on federal and state marketplaces will see new rules to make coverage fairer and easier to use. These changes affect insurance companies, agents, and people buying plans, including new fees, penalties, and better protections for those with hardships. Expect updates on plan quality, dental coverage limits, and longer-term catastrophic plans, all aiming to keep your health coverage solid and affordable.
2026-07205 — Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; Interoperability Standards and Prior Authorization for Drugs for Medicare Advantage Organizations, Medicaid Managed Care Plans, State Medicaid Agencies, Children's Health Insurance Program (CHIP) Agencies and CHIP Managed Care Entities, and Issuers of Qualified Health Plans on the Federally-Facilitated Exchanges
This new rule will help Medicare, Medicaid, CHIP, and health plan companies share patient info more easily and speed up drug approval requests. It affects Medicare Advantage, Medicaid, CHIP, and health plans on federal exchanges, aiming to make care smoother and faster. These changes will start soon and could save time and money by cutting red tape.
2026-04797 — Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program; Correction
This document fixes some typos and technical mistakes in the Medicare and Medicaid payment rules for 2026. It affects doctors, healthcare providers, and anyone using Medicare Part B by clarifying payment policies and program requirements starting January 1, 2026. These corrections help make sure payments and coverage rules are clear and accurate, so everyone gets paid right and on time.
2026-04467 — Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program; Correction
This correction fixes some missing labels in important tables from the 2027 health insurance rules under the Affordable Care Act. It mainly affects insurance companies and people using marketplace plans by clarifying how risk and payments are calculated. These fixes take effect right away on March 6, 2026, ensuring everyone has clear info before the 2027 plan year starts.
Previous / Next Documents
Previous: 2026-11617 — High Purity Dissolving Pulp From Brazil and Norway; Scheduling of the Final Phase of Countervailing Duty and Antidumping Duty Investigations
The U.S. is officially moving forward with a big investigation into whether imports of high purity dissolving pulp from Brazil and Norway are unfairly hurting American businesses. This pulp might be getting special government help or sold too cheaply, so the government is checking if extra taxes (duties) should be added to level the playing field. The final decision phase started on May 27, 2026, and could impact prices and trade rules soon.
Next: 2026-11619 — Notice of Public Meeting of the Virginia Advisory Committee to the U.S. Commission on Civil Rights
The Virginia Advisory Committee to the U.S. Commission on Civil Rights is hosting a free, public Zoom meeting on July 24 to hear experts talk about how Virginia public universities are following rules related to student admissions fairness. Anyone interested can join, share their thoughts, or send written comments within 30 days after the meeting. This is a great chance for students, families, and community members to get involved and learn more about fairness in college admissions.